加载中…
This paper proposes a new method for analysis of adverse event data in clinical trials. The method is illustrated by application to data on 4 phase III clinical trials, two on breast cancer and two on diabetes mellitus.

生成讲解博客的中文版本

生成AI智能校验的中文版本